Efficacy of tiotropium bromide and rehabilitation treatment on pulmonary function of patients with sulfur mustard lung injury

Iranian Red Crescent Medical Journal

Volumn 17, Issue 12, 2015, Pages 1-6

  Shohrati, Majid ^a   Jalili, Maryam ^b   Afshar, Homa ^b   Najafian, Bita ^a   Qazvini, Ali ^a   Zaeri, Meysam ^c   Harandi, Ali Amini ^d   Ghanei, Mostafa ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bronchiolitis obliterans; Exercise test; Plethysmography; Rehabilitation; Sulfur mustard; Tiotropium

Indexed keywords

TIOTROPIUM BROMIDE;

ADULT; ARTICLE; BOOTSTRAPPING; CARDIOPULMONARY EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PLETHYSMOGRAPHY; PROBABILITY; PULMONARY REHABILITATION; RESIDUAL VOLUME;

EID: 84951034144     PISSN: 20741804     EISSN: 20741812     Source Type: Journal    
DOI: 10.5812/ircmj.20026     Document Type: Article

References (29)

1. Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol. 2007; 19(5):451–6. doi: 10.1080/08958370601174990. [PubMed: 17365048]
2. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med. 2003; 45(11):1136–43. doi: 10.1097/01.jom.0000094993.20914.d1. [PubMed: 14610394]
3. Ghanei M, Tazelaar HD, Chilosi M, Harandi AA, Peyman M, Akbari HM, et al. An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med. 2008; 102(6):825–30. doi: 10.1016/j.rmed.2008.01.016. [PubMed: 18339530]
4. Ghasemi H, Owlia P, Jalali-Nadoushan MR, Pourfarzam S, Azimi G, Yarmohammadi ME, et al. A clinicopathological approach to sulfur mustard-induced organ complications: a major review. Cutan Ocul Toxicol. 2013; 32(4):304–24. doi: 10.3109/15569527.2013.781615. [PubMed: 23590683]
5. Ghanei M, Fathi H, Mohammad MM, Aslani J, Nematizadeh F. Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol. 2004; 16(8):491–5. doi: 10.1080/08958370490442421. [PubMed: 15204740]
6. Burgel PR, Paillasseur JL, Dusser D, Roche N, Liu D, Liu Y, et al. Tiotropium might improve survival in subjects with COPD at high risk of mortality. Respir Res. 2014; 15:64. doi: 10.1186/1465-9921-15-64. [PubMed: 24913266]
7. Troosters T, Demeyer H, Hornikx M, Camillo CA, Janssens W. Pulmonary rehabilitation. Clin Chest Med. 2014; 35(1):241–9. doi: 10.1016/j.ccm.2013.10.006. [PubMed: 24507849]
8. Nici L, ZuWallack RL. Pulmonary rehabilitation: future directions. Clin Chest Med. 2014; 35(2):439–44. doi: 10.1016/j.ccm.2014.02.015. [PubMed: 24874138]
9. Jacome C, Marques A. Impact of pulmonary rehabilitation in subjects with mild COPD. Respir Care. 2014; 59(10):1577–82. doi: 10.4187/respcare.03091. [PubMed: 24803497]
10. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005; 26(2):319–38. doi: 10.1183/09031936.05.00034805. [PubMed: 16055882]
11. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26(3):511–22. doi: 10.1183/09031936.05.00035005. [PubMed: 16135736]
12. Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005; 172(1):19–38. doi: 10.1164/rccm.200408-1109SO. [PubMed: 15778487]
13. Hasegawa M, Makita H, Nasuhara Y, Odajima N, Nagai K, Ito Y, et al. Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD. Thorax. 2009; 64(4):332–8. doi: 10.1136/thx.2008.103671. [PubMed: 19074932]
14. Montuschi P, Macagno F, Valente S, Fuso L. Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD. Curr Med Chem. 2013; 20(12):1464–76. [PubMed: 22963553]
15. Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002; 19(2):209–16. [PubMed: 11871363]
16. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359(15):1543–54. doi: 10.1056/NEJMoa0805800. [PubMed: 18836213]
17. Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Molken MP, Beeh KM, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med. 2011; 364(12):1093–103. doi: 10.1056/NEJMoa1008378. [PubMed: 21428765]
18. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest. 2005; 128(4):2025–34. doi: 10.1378/chest.128.4.2025. [PubMed: 16236851]
19. Plankeel JF, McMullen B, MacIntyre NR. Exercise outcomes after pulmonary rehabilitation depend on the initial mechanism of exercise limitation among non-oxygen-dependent COPD patients. Chest. 2005; 127(1):110–6. doi: 10.1378/chest.127.1.110. [PubMed: 15653970]
20. Farid R, Azad FJ, Atri AE, Rahimi MB, Khaledan A, Talaei-Khoei M, et al. Effect of aerobic exercise training on pulmonary function and tolerance of activity in asthmatic patients. Iran J Allergy Asthma Immunol. 2005; 4(3):133–8. [PubMed: 17301436]
21. Casaburi R, Porszasz J, Burns MR, Carithers ER, Chang RS, Cooper CB. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997; 155(5):1541–51. doi: 10.1164/ajrccm.155.5.9154855. [PubMed: 9154855]
22. Puente-Maestu L, Sanz ML, Sanz P, Cubillo JM, Mayol J, Casaburi R. Comparison of effects of supervised versus self-monitored training programmes in patients with chronic obstructive pulmonary disease. Eur Respir J. 2000; 15(3):517–25. doi: 10.1002/cne.901830305. [PubMed: 10759446]
23. Casaburi R, Kukafka D, Cooper CB, Witek TJ, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005; 127(3):809–17. doi: 10.1378/chest.127.3.809. [PubMed: 15764761]
24. Pitta F, Brunetto AF, Padovani CR, Godoy I. Effects of isolated cycle ergometer training on patients with moderate-to-severe chronic obstructive pulmonary disease. Respiration. 2004; 71(5):477–83. doi: 10.1159/000080632. [PubMed: 15467325]
25. O'Donnell D E. [Dynamic lung hyperinflation and its clinical implication in COPD]. Rev Mal Respir. 2008; 25(10):1305–18. [PubMed: 19107020]
26. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998; 30(6):975–91. [PubMed: 9624661]
27. Thomason JW, Rice TW, Milstone AP. Bronchiolitis obliterans in a survivor of a chemical weapons attack. JAMA. 2003; 290(5):598–9. doi: 10.1001/jama.290.5.598. [PubMed: 12902361]
28. Ghanei M, Mokhtari M, Mohammad MM, Aslani J. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol. 2004; 52(2):164–9. doi: 10.1016/j.ejrad.2004.03.018. [PubMed: 15489074]
29. Nici L, ZuWallack RL. Pulmonary rehabilitation: today and tomorrow. Breathe. 2010; 6(4):305–11.